Edgar V. Lerma πŸ‡΅πŸ‡­ Profile picture
Chicago Sports Fan... Nephrologist by day. My tweets are not medical advice. The views expressed here are my own and not those of my employer.

Feb 26, 2022, 9 tweets

Advancing Evidence-Based Care in Diabetes and CKD
#ISNWCN πŸ‡²πŸ‡Ύ #Nephpearls

πŸ‘‰ kdigo.org/wp-content/upl…

Holistic approach for improving outcomes in patients with Diabetes and CKD
#ISNWCN πŸ‡²πŸ‡Ύ #Nephpearls

Glucose-lowering agents in Type 2 Diabetes (T2D) and CKD: Indications and dose adjustments
#ISNWCN πŸ‡²πŸ‡Ύ #Nephpearls

Mitigation strategies vs side effects of SGLT2inhibitors and GLP-1 Receptor agonists
#ISNWCN πŸ‡²πŸ‡Ύ #Nephpearls

More on SGLT2 inhibitors:
πŸ“Œ Expanded indications
πŸ“Œ Initiation
πŸ“Œ Dosing recommendations
#ISNWCN πŸ‡²πŸ‡Ύ #Nephpearls

FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline

FIDELIO-DKD nejm.org/doi/full/10.10…
FIGARO-DKD nejm.org/doi/full/10.10…
FIDELITY academic.oup.com/eurheartj/arti…

#VisualAbstract by @whatsthegfr
#ISNWCN πŸ‡²πŸ‡Ύ #Nephpearls

DE BOER: New recommendation for non-steroidal MRA
#ISNWCN πŸ‡²πŸ‡Ύ #Nephpearls

Potassium management with Finerenone
#ISNWCN πŸ‡²πŸ‡Ύ #Nephpearls

CHAN: Dietary management in patients with T2D and CKD - 10 Tips to cut salt πŸ§‚
#ISNWCN πŸ‡²πŸ‡Ύ #Nephpearls

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling